ABSTRACT: Revisions TKAs are being completed with uncemented constructs more frequently. We hypothesized that tantalum cones could be an efficient carrier of antibiotics in uncemented procedures. We aimed to compare the release of vancomycin between (i) tantalum and smooth stainless cylinders; (ii) different concentrations of vancomycin; and (iii) different durations of bathing. Specifically designed tantalum cylinders were bathed in a vancomycin solution with various durations of baths. We investigated rinses between each interval as well as the dose of vancomycin. Vancomycin concentrations were determined in each group by fluorescence polarization immunoassay at different intervals (1 h, days 1, 2, 3, 5). At 1 h, the mean vancomycin concentration for the 1-hour soaking group was 3,172 mg/ml, whereas mean concentration for the smooth stainless steel group was 39.37 mg/ml (p < 0.001). The rinsing group showed a significantly lower concentration at 1 h and 1 day (p < 0.05). The 2-gram vancomycin group showed no difference at days 1, 2, and 3 compared to the 1-hour group. The 5, 15, and 30-minute bathing groups showed significantly lower vancomycin concentrations at alltime points. All vancomycin concentrations at day 3 were superior to the minimal inhibitory concentration of Staphyloccocus aureus. The mean concentration of vancomycin depends on the material, duration of bathing, the rinsing effect, and the drug dose. Our in-vitro study is the first to show that porous tantalum cylinders allow antibiotic carriage and progressive release. If appearing in vivo, in a similar extent, this intrinsic property might be useful to prevent and/or treat peri-prosthetic joint infection. ß
The demand for primary total knee arthroplasties (TKAs) is expected to grow by 673% to 3.48 million annual procedures. 1 From the initial hip or knee primary arthroplasty, there is a 30% to 45% likelihood that patients will undergo an arthroplasty in the contralateral cognate joint. 2 TKA revisions are also projected to increase by 601% from 2005 to 2030. 1 Periprosthetic joint infection (PJI) accounts for one of the most common reasons for revision. 3 Of these PJIs, Staphylococcus aureus (S. aureus) account for 51% of PJIs after TKA in United States, (US) and for 49% in Europe. 4 Percentage of methicillin-resistant S. aureus (MRSA) account for 48% of PJIs in the United States. 4 Vancomycin, however, is effective against nearly all Staphylococci and according to the recent literature, vancomycin appears to be the least toxic antibiotic for the local environment. 5, 6 While multiple solutions have been proposed to both prevent and treat PJI, the possibility to deliver local antibiotics through orthopedic implants remains a challenge. Antibiotic-loaded bone cement is frequently employed in the complex primary and many revision settings to mitigate the risk of PJI 7 given the fact that local antibiotics can be administered at much higher concentrations than achievable with parenteral antibiotics and without systemic toxicity. [8] [9] [10] [11] [12] [13] Furthermore, antibiotic-loaded bone cement facilitates delivery of antibiotics to avascular areas of the joint that are inaccessible when using parenteral treatment alone. 14, 15 However, over the past decade, we have seen an increasing trend towards the utilization of uncemented metaphyseal fixation during revision TKAs. [16] [17] [18] While there are currently several products available on the market, one of the first was with tantalum femoral and tibial cones. [19] [20] [21] [22] Tantalum is an exciting biomaterial given its low stiffness, high porosity (75-80%), high biocompatibility, and its ability to undergo osseointegration. 23, 24 While some have hypothesized that tantalum itself minimizes the risk of PJI given its topographic structure, recent in vitro study demonstrated that the tantalum alone has no intrinsic anti-microbial property. 25, 26 Based upon the wealth of data surrounding antibiotic-loaded bone cement in revision TKAs, combined with the significant trend towards uncemented metaphyseal fixation, we sought to determine the effectiveness and reliability of local antibiotics from tantalum in an effort to potentially prevent and treat PJIs in the revision setting. We hypothesized that in a clinician-directed fashion, tantalum cones could be an efficient and a reliable carrier of local antibiotics. In particular, we aimed to compare the release of vancomycin between (i) tantalum and smooth stainless steel cylinders; (ii) different concentrations of vancomycin baths; and (iii) different durations of vancomycin baths.
MATERIALS AND METHODS
Sterile and standardized (1 cm 3 ) tantalum cylinders (Trabecular Metal TM ; Zimmer-Biomet; Warsaw, IN) were specifically designed for this study to study the ability of vancomycin to be eluted in a clinician-directed fashion (similar to antibiotic-loaded bone cement).
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Vancomycin Elution Properties
The first step involved evaluating the elution properties of vancomycin utilizing ten tantalum cylinders loaded with vancomycin via a standardized soaking process as described below. The vancomycin solution [50 mg/ml] was reconstituted by adding 20 ml of sterile saline (H 2 O, pH 5.5, osmolarity: 0 mOsmol/L; Lavoisier, France) to 1 g of dry vancomycin powder (Sandoz, France). Each tantalum cylinder was placed in an individual beaker and completely covered by the solution at room temperature for 1 h. After this soaking period, cylinders were withdrawn with sterile forceps and immersed in 5 ml of phosphate-buffered saline (PBS) at a pH 7.4.
To define the vancomycin elution properties, a 1.5 ml sample was taken from each cylinder after 1 h. Thereafter, each experimental cylinder was immediately placed into a fresh 5 ml PBS solution bath. This process was repeated at days 1, 2, 3, and 5 ( Fig. 1 ). Ten stainless smooth steel cylinders (all measuring 1 cm 3 ) were used as control samples, and followed the exact same protocol.
Vancomycin Baths Concentrations Change
After the above protocol was completed, the impact of rinsing, as well as modifications to vancomycin bath concentrations, was analyzed on both tantalum and smooth stainless steel cylinders. To evaluate the impact of rinsing, ten tantalum cylinders and ten smooth stainless steel cylinders were rinsed with 5 ml of PBS baths before each new PBS solution immersion occurred. To evaluate the vancomycin saturation threshold, ten tantalum cylinders and ten stainless steel cylinders were loaded in a bathing solution containing a concentration of vancomycin that was double the prior experiment (i.e., 2 g diluted in 20-ml of sterile saline resulting in 100 mg/ml concentration).
Duration of Vancomycin Baths
To evaluate the impact of the bathing duration, three groups of ten tantalum cylinders and three groups of ten smooth stainless steel cylinders were soaked for three different durations: 5 min, 15 min, and 30 min. The vancomycin concentration of the bath was the same as the original 1-hour bathing group (50 mg/ml). The remaining elution protocol was as described above, with comparisons made to the groups of cylinder soaked for 1 h.
For each sample, the concentration of vancomycin was analyzed following the same standardized protocol. 27 The samples were preserved at À40˚C and defrosted before being assayed. Vancomycin concentrations were determined by fluorescence polarization immunoassay (Cobas Integra 400þ; Roche Diagnostic, Mannheim, Germany). 28 Intra-and interday precision accuracy values were within 15%. 28 The limit of quantification was 0.76 mg/ml. The level of vancomycin was considered as bactericidal if the measured concentration was greater than the minimal inhibitory concentration (MIC) for the Staphylococcus aureus (i.e., MIC> 2 mg/ml).
29

Statistical Analysis
The amount of antibiotic released from each cylinder at the different times of sampling, or for the different timing or concentration of bathing, was calculated by measuring the antibiotic concentration of each sample at each time point, and then multiplying by the constant volume of the chamber (i.e., 5 ml). To evaluate the vancomycin elution properties, the tantalum cylinders were compared with the smooth stainless steel cylinders at the different times using Wilcoxon non-parametric testing to estimate mean differences and related 95% confidence interval (CI).
To evaluate the effect of initial bath concentration, the 1-hour tantalum cylinders with standard concentration (50 mg/ml) were compared with the rinsed group and with the double concentration (100 mg/ml) group using also Wilcoxon non-parametric testing. To evaluate the effect of the duration of bathing, the eluted antibiotic concentrations were compared between the 1 h, 5-minute, 15-minute, and 30-minute groups using also Wilcoxon non-parametric testing. Sample size was estimated with a post-hoc analysis based on our 1-hour concentration analysis (mean value of 3171.9 AE 25 mg/ml). As such, our study was able to distinguish difference >300 mg/ml between groups with a statistical power of 80%. We considered p < 0.05 as significant.
RESULTS
Vancomycin Elution Properties
The results of the vancomycin elution for the 1-hour soaking process showed a 20.8 mg mean total antibiotic release of vancomycin, which represents 2.1% of total vancomycin present in the soaking bath (Table 1 ). 
VANCOMYCIN ELUTION FROM TANTALUM
Initially, the tantalum cylinders showed a high release of the loaded vancomycin. The mean maximum concentration observed during the first hour was 3172 mg/ml (Fig. 2) . This concentration exponentially decreased (at day 3 ¼ 23.12 mg/ml) until day 5, when the vancomycin concentration becomes undetectable. The mean vancomycin concentration of the control group with stainless steel cylinders was 39.37 mg/ml at 1 h (mean difference of 3133 mg/ml with 95% CI of 3015-3250; p < 0.0001). At only 1 day, vancomycin was completely undetectable in the stainless steel group.
Vancomycin Loading Concentrations
The amount of vancomycin released from the rinsed tantalum cylinders was lower than the amount released by cylinders that had not been rinsed before elution (Table 1) . However, the difference decreased throughout the experiment and, at day 5, both rinsed and un-rinsed cylinders stopped releasing vancomycin. The amount of vancomycin released in the tantalum cylinder group with the initial double concentration of vancomycin (100 mg/ml) was significantly higher (24.72 mg) than the amount released by the tantalum cylinders (15.86 mg) loaded with the standard concentration of vancomycin (50 mg/ml) at 1 h (p < 0.0001). Again, the difference decreased throughout the experiment and no vancomycin was detected at day 5 in either group. At day 1, vancomycin was completely undetectable in the stainless steel group regardless of concentration change or rinsing process.
Impact of Loading Duration
The mean concentration of vancomycin in the tantalum cylinders was influenced by shorter bathing durations of 5, 15, and 30 min, respectively, as noted in the significantly lower concentrations of vancomycin elution when compared to the one-hour bathing group (p < 0.001 at all time points except group 5 min at 1 h). At day 1, mean vancomycin concentrations were 258.07 mg/ml (bath of 5 min), 251.88 mg/ml (15 min), and 195.28 mg/ml (30 min) (Fig. 2) . The mean concentration for each group decreased exponentially thereafter. At day 1, vancomycin was completely undetectable in the stainless steel group regardless of bath duration (p < 0.001).
DISCUSSION
While several surgeons have utilized antibiotic-loaded bone cement in high-risk primary TKAs, revision TKAs, and during a two-stage exchange protocol, the trend has been towards uncemented metaphyseal fixation for long-term biologic fixation. As such, we sought to determine an effective and a reliable delivery of local antibiotics through tantalum. In this in vitro investigation, we were able to show that tantalum cylinders have the ability to release vancomycin for four days in comparison to smooth stainless steel cylinders. Moreover, the concentration of eluted vancomycin was dependent on the duration of the bathing as well as the concentration of vancomycin in the bath.
The result of our study regarding elution properties of tantalum demonstrated the ability to deliver vancomycin during 4 days in a liquid medium of PBS. The elution rate observed at 1-hour was the highest and the mean elution rate decreased exponentially thereafter (Fig. 2) . The high initial release was probably related to the release of the vancomycin trapped at the surface of the tantalum. This elution release profile is similar to the elution release profile of antibiotics from cement, calcium phosphate cement beads 27, 30 . In our study, a single 1-cm 3 tantalum cylinder was able to absorb and release at least 20 mg out of 1 g of vancomycin. However, in the control group of stainless steel cylinders, only negligible traces of vancomycin were observed at 1 h and none was detectable at 24 h. To our knowledge, this study is the first study to report the vancomycin elution properties from tantalum cylinders, which limits the comparison with previously published studies. 27, 30 The results of our study demonstrated that even rinsed, tantalum cylinders significantly delivered vancomycin during at least 4 days. Despite this rinsing effect, concentrations observed at day 3 were higher than the maximum MIC for Staphylococcus aureus (clinical breakpoint: 2 mg/ml), 29 which means that vancomycin could have therapeutic activity during at least 3 days even when rinsed. This observation is consistent with the hypothesis that the critical amount of vancomycin released is within the first hour and related to antibiotic molecules trapped at tantalum surface. This is clinically relevant since blood and routine sterile saline irrigation at the time of primary or revision TKAs will not mitigate the elution of vancomycin from the tantalum. In addition, the elution curve for the double-dose vancomycin group showed that concentrations were higher than the simple-dose group at 1-hour only. The spaces between the interconnected pores of the tantalum cylinders might be saturated by a certain amount of vancomycin and the excess of vancomycin remains on the external surface.
The effect of the bathing duration on vancomycin elution was essential since a clinical application would require surgeons to apply an intraoperative bath to tantalum components during surgery. In the current study, 1 h of bathing was used as the reference, but we also compared different bathing durations of 5, 15, and 30 min with the same vancomycin concentration. While no difference was found between 5, 15, and 30-minute groups, all were lower than the group that was bathed with the vancomycin solution for 1 h. Importantly, however, the vancomycin concentration that eluted over 3 days was still over the MIC for Staphylococcus aureus in the 5, 15, and 30 min bath groups. 29 The major limitation of this study is that these in vitro findings may not replicate in vivo release of vancomycin. However, our study design was robust with different concentrations of vancomycin evaluated, various durations of bathing, and impact of rinsing investigation. Moreover, our study was similar to previously validated protocols. 27, [29] [30] A second limitation includes the fact that we only evaluated one antibiotic-vancomycin. Several PJIs require other antibiotics to treat the infection, and future investigations in our lab are focused on similar studies with other antibiotics. Finally, we only evaluated a single clinically relevant biomaterial-tantalum. Clearly future investigations are needed studying other biomaterials that are frequently utilized in clinical practice.
In conclusion, the result of our study revealed the in vitro ability of vancomycin to be released from tantalum cylinders at a much higher dose than with smooth stainless steel cylinders. In addition, higher concentrations of vancomycin were released when the concentration of vancomycin was increased, the cylinders were not rinsed, and the duration of bathing was 1 h. The results of this study are encouraging in the complex primary and most revision settings where biologic fixation, particularly in the metaphysis, is increasingly utilized in these patients who are at high risk for periprosthetic joint infection.
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